Commensurate with improved anti-tumor potential, deficiency of CD38 substantially increased the functionality of adoptively transferred T cells (Vβ13+CD8+ T cells) at the tumor site compared to WT Pmel T cells (Fig. 4F). This evidence concerns the gene CD38 and neoplasm.